Greenline Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Hold |
28,711
| – | – | 0.32% | 65 |
|
|
2025
Q1 | $2.33M | Hold |
28,711
| – | – | 0.34% | 65 |
|
|
2024
Q4 | $2.59M | Hold |
28,711
| – | – | 0.36% | 62 |
|
|
2024
Q3 | $2.84M | Hold |
28,711
| – | – | 0.41% | 56 |
|
|
2024
Q2 | $2.67M | Hold |
28,711
| – | – | 0.41% | 57 |
|
|
2024
Q1 | $2.72M | Hold |
28,711
| – | – | 0.43% | 52 |
|
|
2023
Q4 | $2.56M | Buy |
+28,711
| New | +$2.56M | 0.43% | 54 |
|